Insurance |
Private versus not insured |
2.167 (0.663, 7.087) |
1.637 (1.178, 2.275) |
<0.001 |
Medicaid versus not insured |
1.116 (0.241, 5.175) |
1.399 (0.938, 2.085) |
|
Medicare versus not insured |
1.793 (0.550, 5.848) |
1.263 (0.908, 1.756) |
|
Other versus not insured |
1.361 (0.133, 13.920) |
2.231 (1.200, 4.149) |
|
Income |
$30,000–34,999 versus $30,000 |
1.765 (0.932, 3.344) |
1.112 (0.915, 1.351) |
0.009 |
$35,000–45,999 versus <$30,000 |
1.783 (0.980, 3.242) |
1.140 (0.954, 1.362) |
|
>46,000 versus <$30.000 |
2.301 (1.305, 4.057) |
1.292 (1.090, 1.532) |
|
Facility type |
Comprehensive versus community |
3.960 (1.439, 10.895) |
1.167 (0.972, 1.401) |
<0.001 |
Academic versus community |
8.569 (3.109, 23.615) |
1.286 (1.060, 1.560) |
|
Size |
No tumor versus >5 cm |
11.104 (0.000, I) |
16700.73 (0.000, 1.78E148) |
<0.001 |
<1 versus >5 cm |
1.779 (0.946, 3.342) |
2.282 (1.853, 2.811) |
|
1–2 versus >5 cm |
1.683 (0.963, 2.939) |
1.878 (1.534, 2.299) |
|
2–3 versus >5 cm |
1.911 (1.136, 3.215) |
1.329 (1.079, 1.637) |
|
3–4 versus >5 cm |
2.386 (1.440, 3.952) |
1.474 (1.190, 1.825) |
|
4–5 versus >5 cm |
1.571 (0.887, 2.784) |
1.289 (1.021, 1.628) |
|
Histology |
Neuroendocrine versus adenocarcinoma |
0.539 (0.216, 1.343) |
1.462 (1.231, 1.736) |
<0.001 |
Other versus adenocarcinoma |
1.209 (0.423, 3.453) |
0.471 (0.321, 0.692) |
|